Vivos Therapeutics Interest Expense 2011-2026 | VVOS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Vivos Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-110 K	-212 K	-190 K	14 K	96 K	138 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
138 K	-212 K	-44 K

Quarterly Interest Expense Vivos Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
500 K	-163 K	-4 K	-	-18 K	-22 K	-1 K	-	-53 K	-225 K	51 K	-	-36 K	-37 K	-	-	9.49 K	251	82	-	17 K	18.1 K	43.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
500 K	-225 K	4.74 K

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
Xtant Medical Holdings XTNT	4.16 M	$ 0.55	-2.31 %	$ 73.5 M	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	-2.76 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Zimmer Biomet Holdings ZBH	-31.1 M	$ 88.57	-0.65 %	$ 18 B	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Alphatec Holdings ATEC	45.9 M	$ 10.93	-5.12 %	$ 1.64 B	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Accuray Incorporated ARAY	559 K	$ 0.4	4.21 %	$ 41.1 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	947 K	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
CONMED Corporation CNMD	31.1 M	$ 34.58	-5.62 %	$ 1.07 B	USA
NanoVibronix NAOV	135 K	-	-	$ 1.08 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Aethlon Medical AEMD	10.1 K	$ 2.15	-5.29 %	$ 3.36 M	USA
Edwards Lifesciences Corporation EW	7.2 M	$ 79.34	-3.36 %	$ 46.4 B	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	-274 K	$ 11.2	-1.84 %	$ 1.51 B	USA
OrthoPediatrics Corp. KIDS	6.05 M	$ 15.52	-5.08 %	$ 364 M	USA
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	99 K	-	10.0 %	$ 610 K	USA
Myomo MYO	-668 K	$ 0.7	2.32 %	$ 29.3 M	USA
Penumbra PEN	893 K	$ 335.1	-0.39 %	$ 13 B	USA
Inspire Medical Systems INSP	-2.66 M	$ 50.13	-0.63 %	$ 1.47 B	USA
Pulmonx Corporation LUNG	790 K	$ 1.17	-5.65 %	$ 47.6 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
NuVasive NUVA	-21.4 M	-	-	$ 2.07 B	USA
Nevro Corp. NVRO	-421 K	-	-	$ 217 M	USA
Surgalign Holdings SRGA	1.01 M	-	-32.98 %	$ 1.68 M	USA
STRATA Skin Sciences SSKN	926 K	-	-	$ 6.6 M	USA
AVITA Medical RCEL	5 M	$ 3.82	-1.04 %	$ 106 M	Australia
AxoGen AXGN	167 K	$ 31.28	-3.01 %	$ 1.44 B	USA
Delcath Systems DCTH	-70 K	$ 8.97	-1.75 %	$ 321 M	USA